Immunohistochemical analysis using CD31 and Ki67 markers revealed that curcumol reduces tumor proliferation and microvessel density in a dose-dependent manner, with high-dose curcumol demonstrating efficacy comparable to oxaliplatin. The gene discussed is MKI67; the disease is neoplasm.